Here, we review recent findings focused on the role of FABP4 in lipid metabolism, particularly lipid metabolism, in obesity, the possible molecular mechanism of carcinogenesis, and potential therapeutic targets, including breast, ovarian, liver, stomach, and pancreatic cancers. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.